Skip to content

Intraoperative measurement of hepatic rigidity

Intraoperative measurement of hepatic rigidity - DuroLeb

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021204
Enrollment
50
Registered
2021-01-12
Start date
2020-06-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K74.0 K74.1 C22.0 C78.7 K70 K73 K75 K76

Interventions

Group 1: In patients with indicated and planned laparotomy, the degree of rigidity of the liver is measured intraoperatively in vivo on healthy organs and ex vivo on pathologically altered resectates

Sponsors

Universitätsklinik für Viszeralchirurgie - PIUS-Hospital Oldenburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age of majority - indicated laparotomy, if an adequate measurement can be made under the given surgical incision - Period: April 2020 to April 2021

Exclusion criteria

Exclusion criteria: - Minority - Cases outside the period from April 2020 to April 2021 - Insufficient knowledge of the German language - Refusal to participate in the study - Withdrawal at the request of the patient

Design outcomes

Primary

MeasureTime frame
Rigidity of healthy and abnormally changed livers in vivo in indicated laparotomies as well as ex vivo from resected parts of the liver, measured by durometer.

Secondary

MeasureTime frame
- correlation between liver rigidity and the Hounsfield scale or values extracted from the MRI sequences - correlation between liver rigidity and different liver-specific laboratory values (alanine aminotransferase (ALT, ALAT)/glutamate pyruvate transaminase (GPT), aspartate aminotransferase (AST)/glutamate oxaloacetate transaminase (GOT), gamma-glutamyltransferase (gamma-GT), alkaline phosphatase (AP), lactate dehydrogenase (LDH), alpha-foetoprotein (AFP), bilirubin (direct, indirect), quick value / INR, antithrombin, platelets, ammonia, albumin, cholinesterase, hepatitis serology, serum ferritin) - Relation between liver hardness and liver diseases (hepatitis, HCC, liver cirrhosis, sclerosing cholangitis, alveolar echinococcosis, cystic echinococcosis)

Countries

Germany

Contacts

Public ContactDaniela Salzmann

Universitätsklinik für Viszeralchirurgie Universitätsmedizin Oldenburg, Pius-Hospital Oldenburg

daniela.salzmann@uol.de0441-2291991

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026